Antimicrobial resistance among Campylobacter isolates is an increasing problem all over the world. In particular, resistance to fluoroquinolones increased dramatically during the 1990s ([2][1], [5][2]). At present, susceptibility testing of Campylobacter is important for both clinical and
No takes yet. Share an insight, caveat, or question.
Hakanen et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: